Although earlier studies have identified c-MET expression in ESCC, its prognostic value and therapeutic potential as a therapeutic target remain unclear, mainly due to differences in methodology and research priorities across studies, which have led to divergent understandings of c-MET’s action. This evidence concerns the gene MET and esophageal squamous cell carcinoma.